on Evotec AG (NASDAQ:EVTCY)
Evotec SE to Release 2024 Financial Results on April 17, 2025
Evotec SE, listed on both Frankfurt and Nasdaq, has announced it will present its financial outcomes for the fiscal year 2024 on April 17, 2025. A conference call will accompany the announcement, featuring a discussion on the 2024 results and insights from a concluded strategic review. This call will be conducted in English.
Interested parties can attend the webcast on April 17 at 2.00 pm CEST. Evotec has provided registration links for participation through phone or audio webcast. Additionally, presentation slides will be accessible for attendees. The on-demand webcast will be available on the company's website afterward.
Evotec continues its mission to innovate in therapeutic discoveries with a broad pipeline across various medical fields. As of now, the company employs over 4,800 staff worldwide.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Evotec AG news